Thermo Fisher Scientific Ocrelizumab Humanized Recombinant Human Monoclonal Antibody

Applications

ELISA

• Tested Dilution: 1:5,000–1:10,000

Product Specifications

Product Specific Information

• Endotoxin level: < 0.01 EU/µg (LAL method)
• Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
• Store at 2–8°C for one week.
• Store at -20 to -80°C for twelve months from the date of receipt.

Target Information

Ocrelizumab is a CD20-directed cytolytic antibody indicated for the treatment of patients with relapsing or primary progressive forms of multiple sclerosis. It is a second-generation recombinant humanized monoclonal IgG1 antibody that selectively targets B lymphocytes expressing the CD20 antigen. As a humanized molecule, ocrelizumab is expected to be less immunogenic with repeated infusions, improving the benefit-to-risk profile for patients with relapsing or progressive forms of MS.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.